What is the procedure to get a Fine Needle Aspiration Cytology (FNAC) for a Wharton tumor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

FNAC Procedure for Wharton's Duct Tumor (Submandibular Gland)

For a suspected Wharton's duct tumor (submandibular gland mass), perform ultrasound-guided fine-needle aspiration cytology (FNAC) as the initial diagnostic procedure rather than proceeding directly to open biopsy. 1

Pre-Procedure Preparation

  • Confirm the mass location and characteristics through physical examination focusing on the submandibular triangle, assessing for size, consistency (firm vs. fluctuant), mobility, fixation to surrounding structures, and associated lymphadenopathy 1
  • Obtain ultrasound imaging first to characterize the lesion (solid vs. cystic components, vascularity, relationship to surrounding structures) and identify the safest needle trajectory 1
  • Review any available CT or MRI to assess depth, relationship to major vessels, and presence of additional masses that might alter the sampling approach 1

FNAC Technique Selection

Use ultrasound guidance for the procedure rather than palpation-guided technique, as this improves accuracy and allows real-time visualization of needle placement 1

Needle Selection

  • Begin with 22-25 gauge needle for initial passes, as smaller needles (25G) have shown diagnostic accuracy of 95.5% for salivary gland lesions 1
  • Consider core needle biopsy (18-20 gauge) if initial FNAC is nondiagnostic, as core biopsy provides tissue architecture and eliminates need for repeat procedures in many cases 1, 2

Sampling Technique

  • Perform multiple passes (4-6 passes minimum) using the "fanning technique" to sample different areas of the mass, as this significantly improves diagnostic yield over single-site sampling 1
  • Do NOT use suction on initial passes for solid salivary gland masses, as suction increases specimen bloodiness without improving diagnostic yield 1
  • If initial aspirate is scant, then apply suction on subsequent passes 1
  • Remove the stylet after the first pass for all subsequent passes, as stylet use increases specimen bloodiness without improving diagnostic accuracy 1

Critical Procedural Considerations

Avoid traversing the primary tumor mass when sampling suspicious lymph nodes, as this can cause tumor seeding and affect staging accuracy 1

Place a marker clip if performing core biopsy to identify the lesion location for surgical planning, particularly if the lesion might be entirely removed during sampling 1

Specimen Handling

  • Arrange for onsite cytopathology evaluation if available, as this increases diagnostic sensitivity from 78.2% to 96.2% and reduces inadequate samples from 12.6% to 1% 1, 3
  • Prepare material for ancillary testing including cell block preparation, immunohistochemistry, and molecular studies, particularly for indeterminate lesions 1, 3
  • Express aspirates onto slides using the stylet for controlled specimen preparation 1

Management Based on FNAC Results

If FNAC Shows Warthin Tumor (Most Common Benign Salivary Tumor)

  • FNAC has 95% accuracy for Warthin tumor diagnosis when combined with clinical findings and Tc-99m scintigraphy 4, 5
  • Conservative observation is acceptable for elderly patients or those unwilling/unable to undergo surgery, as malignant transformation risk is extremely low during follow-up (0% in studies with mean 55-month follow-up) 4, 5
  • Surgical excision remains an option for symptomatic patients or those preferring definitive treatment 4, 5

If FNAC Shows High-Grade Malignancy

  • FNAC has 94.6% sensitivity and 99.2% specificity for high-grade salivary malignancy, making it highly reliable for surgical planning 6
  • Proceed immediately to additional imaging (contrast-enhanced CT/MRI of neck and chest) to assess extent and nodal involvement 6
  • Plan for frozen section biopsy during surgery of both tumor margins and suspicious lymph nodes 6
  • Extend surgical planning to include neck dissection if indicated by imaging, as high-grade FNAC results change surgical extent in 59% of cases 6

If FNAC is Negative or Indeterminate

A negative FNAC never excludes malignancy when clinical suspicion remains high 1, 3

  • If clinical suspicion persists and lymphocytes were seen on FNAC, perform core needle biopsy or proceed to open/excisional biopsy 1
  • If FNAC is technically inadequate (insufficient cells, excessive blood), repeat ultrasound-guided FNAC with fanning technique and without suction 1, 3
  • If repeat FNAC remains nondiagnostic in a suspicious mass, proceed directly to surgical excision rather than continued surveillance 1

Common Pitfalls to Avoid

  • Never rely on FNA alone without imaging guidance for submandibular masses, as blind palpation-guided FNA has significantly lower accuracy 1
  • Do not perform open biopsy before attempting FNAC, as this increases complications, costs, and can compromise subsequent imaging interpretation 1
  • Avoid sampling only the center of large masses, as necrotic centers yield nondiagnostic material; always use peripheral/fanning sampling 1
  • Do not dismiss a benign FNAC result if clinical examination suggests malignancy (rock-hard consistency, fixation, rapid growth, facial nerve involvement), as false-negative rates exist 1, 3, 6

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.